CNE1000035K5
CNE1000035K5
PHARMABLOCK
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 1.974.477.817 | 1.688.619.647 | 16.9% |
| Cost of Revenue | 1.366.023.396 | 1.046.009.644 | 30.6% |
| Gross Profit | 608.454.421 | 642.610.003 | 5.3% |
| 353.834.981 | 342.101.314 | 3.4% | |
| Operating Income | 254.619.440 | 300.508.690 | 15.3% |
| Pretax Income | 207.609.127 | 248.895.878 | 16.6% |
| Net Income Common Stockholders | 183.735.514 | 219.539.834 | 16.3% |
| -- | -- | -- | |
| -- | -- | -- |